Cargando…
Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: a prospective cohort study
BACKGROUND: Carbohydrate antigen 19-9 (CA19-9) is the only biomarker for monitoring responses during treatments of pancreatic cancer, but its accuracy for disease outcome is controversial. Fluid biopsy is a new method for diagnosis and monitoring treatment response. In this study, we investigate the...
Autores principales: | Huang, Chien-Jui, Huang, Wen-Yen, Chen, Chien-Yu, Chao, Ying-Jui, Chiang, Nai-Jung, Shan, Yan-Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210094/ https://www.ncbi.nlm.nih.gov/pubmed/35747164 http://dx.doi.org/10.1177/17588359221106558 |
Ejemplares similares
-
The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer
por: Hou, Ya-Chin, et al.
Publicado: (2022) -
The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study
por: Su, Yung-Yeh, et al.
Publicado: (2023) -
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
por: Shan, Yan-Shen, et al.
Publicado: (2021) -
Subtypes of pancreatic stellate cells and distant metastasis of pancreatic ductal adenocarcinoma
por: Fan, Yuhui, et al.
Publicado: (2020) -
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
por: Koltai, Tomas
Publicado: (2023)